OP-025 Prevalence of Metabolic Syndrome According to Three Criteria in Hypertensive Population in a Rural Hospital Setting

Abstract

Metabolic syndrome is the occurrence of several cardiovascular risk factors in individuals. Several criteria have been proposed to determine its prevalence. To determine and compare the prevalence of metabolic syndrome according to National Cholesterol Education Program Adult treatment Panel III (NCEP ATP III), American Heart Association-National Heart Lung and Blood institute (AHA-NHLB) and the Joint Interim Statement (JIS) criteria in hypertensives attending a rural cardiology clinic. This cross-sectional study used the National Cholesterol Education Program Adult treatment Panel III, American Heart Association-National Heart Lung and Blood institute (AHA-NHLBI) and the joint interim statement criteria to assess metabolic syndrome in 204 patients with arterial hypertension attending cardiology clinic of Federal medical centre (Bida, Nigeria) from February 2010 to April 2013. Two hundred and four hypertensives were enrolled made up of 47.1% males and 52.9% females. Their mean age was 53.43 ± 11.78 years. Using the NCEP ATP III, Eighty three (40.7%) hypertensives had metabolic syndrome (33 males: 16.2%, 50 females: 24.5%) while the application of AHA-NHLBI criteria, resulted in metabolic syndrome in 96 (47.1%) of hypertensives (42 males: 20.6%, 54 females: 26.5% females) and in 108 (52.9%) hypertensive (46 males: 22.5%, 62 females: 33.9% females). The prevalence of metabolic syndrome were significantly higher in both males and females using the JIS compared with the NCEP ATP III, but only in males using the AHA-NHLBI criteria. In both male and female hypertensives with metabolic syndrome, low high densitylipoprotein cholesterol (HDL-C) and abdominal obesity were the most common components (87.9% versus 78%, 78.1% versus 76% and 85% versus 79.6%) respectively. There is a high prevalence of metabolic syndrome in hypertensives in rural Nigeria and varies with criteria used. Theneed for public health promotion, prevention, screening and management of hypertensives for the other components of metabolic syndrome is hereby stressed.